Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

✍ Scribed by Merx, K; Müller, M C; Kreil, S; Lahaye, T; Paschka, P; Schoch, C; Weisser, A; Kuhn, C; Berger, U; Gschaidmeier, H

• Book ID: 110055236
• Publisher: Nature Publishing Group
• Year: 2002
• Tongue: English
• Weight: 147 KB
• Volume: 16
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2402680